Authors:
Puppo, F
Torre, F
Contini, P
Ghio, M
Brenci, S
Brizzolara, R
Sinelli, N
Campo, N
Indiveri, F
Picciotto, A
Citation: F. Puppo et al., Soluble beta(2)-mu-associated and beta(2)-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients.Markers of immune activation, and response to antiviral retreatment, J CLIN IMM, 20(6), 2000, pp. 486-490
Authors:
Campo, N
Brizzolara, R
Sinelli, N
Puppo, F
Campelli, A
Indiveri, F
Picciotto, A
Citation: N. Campo et al., Hepatitis G virus infection in intravenous drug users with or without human immunodeficiency virus infection, HEP-GASTRO, 47(35), 2000, pp. 1385-1388
Authors:
Torre, F
Campo, N
Sinelli, N
Brizzolara, R
Andorno, E
Valente, U
Picciotto, A
Citation: F. Torre et al., Continuous lamivudine treatment in an OLT patient despite the appearance of HBV resistant strain - Longitudinal analysis, TRANSPLANT, 70(7), 2000, pp. 1111-1112
Authors:
Picciotto, A
Campo, N
Brizzolara, R
Sinelli, N
Torre, F
Cipriani, AG
Ponassi, I
Varagona, G
Grasso, A
De Leo, P
De Conca, V
Mesiti, S
Marenco, G
Menardo, G
Dodero, M
Celle, G
Citation: A. Picciotto et al., Interferon retreatment in chronic hepatitis C: which patients to choose, and what schedule to use, EUR J GASTR, 11(6), 1999, pp. 649-653
Authors:
Bagnasco, M
Riccio, AM
Sinelli, N
Campo, N
Battifora, M
Canonica, GW
Picciotto, A
Citation: M. Bagnasco et al., Serum intercellular adhesion molecule-1 and long-term response to IFN-alpha 2b therapy in chronic hepatitis C, J INTERF CY, 18(11), 1998, pp. 963-966